Ann: Healthy Human Trials Commenced & ISO 13485 Certified, page-3

Promising start to life as a listed company. Glad to have topped up my IPO holdings sub 30c.

RAP another UQ technology - listed at a similar period in its commercialisation cycle and ended up being a 25+ bagger. Whilst EMV are also developing hardware, companies like Cochlear trade in the billions once proven.

EMVT is filling an urgent need in diagnosing strokes and internal bleeding events, portably and without harmful ionising radiation. We have a platform technology.

Whilst the small cap market has struggled late, theres every chance EMV will be a standout as validation from clinical trials roll out over the coming year.